Unraveling clonal hematopoiesis of indeterminate potential (CHIP) in cancer: Prevalence, clonal dynamics, and prognostic significance.
Por:
González, AP, Jou, CP, Acha, P, Navarro, V, Palomo, L, Calvete, O, Baraibar, I, Gonzalez, NS, Zamora, E, Sanz, L, Fariñas-Madrid, L, Brana, I, Gonzalez, M, Ristol, F, Diez-Campelo, M, Alfonso-Pierola, A, Bosch, F, Montoro, J and Valcárcel, D
Publicada:
1 jun 2025
Resumen:
Filiaciones:
Univ Hosp Vall dHebron, Vall dHebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain
Vall dHebron Inst Oncol VHIO, Stat Unit, Barcelona, Spain
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol ICO, Hematol Dept, Barcelona, Spain
Inst Recerca Leucemia Josep Carreras, Badalona, Spain
Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
Salamanca IBSAL Univ Hosp, Dept Hematol, Salamanca, Spain
Clin Univ Navarra, Ctr Invest Biomed Red Canc, Dept Oncol Hematol,CIBERONC, Ctr Invest Med Aplicada CIMA,Navarra Univ IDISNA, Pamplona, Spain
|